Dr. Scott has achieved quite a lot in his career journey as a biochemical researcher and as an entrepreneur. Scott Rocklage is currently the managing partner of 5 AM ventures and has vast experience in healthcare management which spans over three decades.
Scott also serves as the chairman of the Boards of Semprus, Relypsa, Kinestral, Rennovia, Cidara Therapeutics and Achaogen.in addition Scott serves as a member of the Boards of Pulmatrix, WavRx, Epirus, Variation and Whitehead Institute of Associates.
Dr. Scott has also worked in various capacities in several organizations such as Cubists Pharmaceuticals where he was the Chairman and CEO. Other companies Scott has worked for include Nycomed Salutar where he was the President and CEO. Scott has also been the R&D of Catalytica and Salutar. Dr. Scott Rocklage has also been previously the Board Chairman of J&J-acquired Novira, Miikana, and Ilypsa.
Dr. Rocklage also boasts of a rich academic background having attended the University of California where he graduated with a Bachelor of Science Degree in Chemistry. He then furthered his education by attending Massachusetts Institute of Technology MIT where he pursued a Doctor of Philosophy Degree in Chemistry. While at Massachusetts Institute of Technology, Scott worked together with Richard R. Schrock a Nobel Prize winner and did his thesis on Schrock’s laboratory.
Dr. Scott rich academic background, vast experience in healthcare management and good strategic leadership abilities played a key role in getting the FDA approval for three New Drugs Applications in the US. These drugs are Cubicin, Teslascan, and Omniscan.
Dr. Scott has also largely contributed to the adoption of six other drugs candidates into clinical tests. Dr. Scott has also helped invent and co-invent over 30 Patents in the U.S. Besides, Dr. Scott has authored more than 100 publications which are subjects to peer reviews.
5 AM Venture LLC is a life science based venture capital firm that helps grow start up sciences businesses. Rocklage joined 5 AM in the year 2003 as a venture partner, and by the end of 2014; he became the firm’s managing partner. Read more: Scott Rocklage | LinkedIn and Idea Mensch | Scott Rocklage
Dr. Scott at 5 AM is involved in studying new aspects of life science and attending board meetings among other roles. Scott being an entrepreneur also works with other Entrepreneurs in the field of life science and helps them with ideas of introducing potential drugs into the market.
Dr. Scott Rocklage has made 5 AM venture the go-to Venture Capital firm for companies interested in life science. Rocklage has embraced the use of modern technology in treating, diagnosing and preventing a wide range of medical problems.